Brief: Cerenis Therapeutics And H4Orphan Pharma Enter Into Exclusive Negotiations For Merger

Abionyx Pharma SA

27/03/2019 17:43

March 27 (Reuters) - CERENIS THERAPEUTICS HOLDING SA
 CEREN.PA :
    * CERENIS THERAPEUTICS AND H4ORPHAN PHARMA ENTER INTO
EXCLUSIVE
NEGOTIATIONS TO CONSIDER A STRATEGIC MERGER
    * COMBINATION WOULD TAKE FORM OF AN ABSORPTION OF H4 ORPHAN
PHARMA
BY CERENIS THERAPEUTICS
    * IF THIS TRANSACTION IS COMPLETED, CERENIS THERAPEUTICS'
SHAREHOLDERS WOULD HOLD 59% OF MERGED ENTITY AND THOSE OF
H4ORPHAN PHARMA 41%
    * TRANSACTION REMAINS SUBJECT TO THE SIGNING OF A MERGER
AGREEMENT
AND THE APPROVAL OF THE SHAREHOLDERS OF CERENIS THERAPEUTICS AND
H4ORPHAN PHARMA

Source text for Eikon:  ID:nBw41MsDZa 
Further company coverage:  CEREN.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com;))